To investigate the effect of galectin-1 ablation on breast cancer cells, we established galectin-1 knock-down cells using two shRNA constructs recognizing different target sequences (Gal-1 sh1 and Gal-1 sh2). The gene discussed is LGALS1; the disease is breast cancer.